A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis (Q82100704)
Jump to navigation
Jump to search
scientific article published on 20 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis |
scientific article published on 20 October 2011 |
Statements
A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis (English)
Kenneth B Gordon
Richard G Langley
Alice B Gottlieb
Gerald G Krueger
David A Williams
Yihua Gu
Joaquin M Valdes
20 October 2011